MRPL40
Basic information
Region (hg38): 22:19432545-19436075
Previous symbols: [ "NLVCF" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MRPL40 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 5 | |||||
missense | 22 | 26 | ||||
nonsense | 0 | |||||
start loss | 1 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 7 | |||||
Total | 0 | 0 | 23 | 10 | 6 |
Variants in MRPL40
This is a list of pathogenic ClinVar variants found in the MRPL40 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
22-19432556-T-C | Uncertain significance (Sep 27, 2022) | |||
22-19432564-T-C | Uncertain significance (Dec 22, 2023) | |||
22-19432565-C-A | Uncertain significance (Jan 28, 2025) | |||
22-19432566-C-T | Likely benign (Dec 06, 2024) | |||
22-19432567-G-C | not specified | Uncertain significance (Feb 17, 2023) | ||
22-19432581-C-G | Uncertain significance (Jun 15, 2023) | |||
22-19432586-T-C | Benign (Feb 03, 2025) | |||
22-19432597-C-T | not specified | Uncertain significance (Jan 22, 2024) | ||
22-19432607-G-A | Uncertain significance (Jun 09, 2024) | |||
22-19433245-C-T | Likely benign (Oct 03, 2023) | |||
22-19433247-T-C | Likely benign (Oct 03, 2023) | |||
22-19433255-T-A | Benign (Dec 26, 2024) | |||
22-19433269-C-T | Likely benign (Oct 15, 2024) | |||
22-19433285-C-G | Uncertain significance (Oct 27, 2023) | |||
22-19433300-C-T | not specified | Uncertain significance (Dec 24, 2024) | ||
22-19433328-C-G | not specified | Uncertain significance (Apr 06, 2023) | ||
22-19433338-A-G | not specified | Uncertain significance (Dec 31, 2024) | ||
22-19433357-C-CA | Likely benign (Nov 23, 2021) | |||
22-19434717-T-C | Likely benign (Apr 16, 2023) | |||
22-19434798-G-A | Uncertain significance (Sep 16, 2024) | |||
22-19434867-C-T | Uncertain significance (Nov 23, 2024) | |||
22-19434884-G-A | Uncertain significance (Nov 21, 2023) | |||
22-19434901-A-C | Likely benign (Oct 29, 2024) | |||
22-19434912-G-A | Likely benign (Oct 20, 2023) | |||
22-19434914-G-C | Benign (Oct 13, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MRPL40 | protein_coding | protein_coding | ENST00000333130 | 4 | 4174 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0529 | 0.929 | 125698 | 1 | 49 | 125748 | 0.000199 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.525 | 122 | 107 | 1.14 | 0.00000558 | 1318 |
Missense in Polyphen | 39 | 32.356 | 1.2053 | 412 | ||
Synonymous | -0.799 | 48 | 41.5 | 1.16 | 0.00000206 | 396 |
Loss of Function | 2.05 | 4 | 11.5 | 0.347 | 6.84e-7 | 122 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000428 | 0.000425 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000169 | 0.000163 |
Finnish | 0.000416 | 0.000416 |
European (Non-Finnish) | 0.0000977 | 0.0000791 |
Middle Eastern | 0.000169 | 0.000163 |
South Asian | 0.000740 | 0.000653 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Pathway
- Mitochondrial translation initiation;Translation;Metabolism of proteins;Mitochondrial translation elongation;Mitochondrial translation termination;Mitochondrial translation
(Consensus)
Recessive Scores
- pRec
- 0.0615
Intolerance Scores
- loftool
- 0.738
- rvis_EVS
- 0.08
- rvis_percentile_EVS
- 60.09
Haploinsufficiency Scores
- pHI
- 0.0442
- hipred
- Y
- hipred_score
- 0.587
- ghis
- 0.527
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.999
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Mrpl40
- Phenotype
Gene ontology
- Biological process
- anatomical structure morphogenesis;mitochondrial translational elongation;mitochondrial translational termination
- Cellular component
- nucleus;mitochondrion;mitochondrial inner membrane;mitochondrial ribosome;mitochondrial large ribosomal subunit
- Molecular function
- RNA binding;protein binding